Understanding the Uterine, Genetic and Timing Factors Behind Repeated IVF and Recurrent Implantation Failure — and How Precision Diagnostics Are Changing Treatment Outcomes – A HealthViews Exclusive with Fertility specialist Dr. Aishwarya Nupur, Founder & Director, Eraya Fertility
For many couples going through IVF, the hardest cycles are rarely the first ones. They are the repeat cycles — when a good-quality embryo still fails to implant, and there is no obvious explanation. This scenario, known clinically as Recurrent Implantation Failure (RIF), was for years managed by simply repeating the same protocol in the hope of a different outcome. That approach is now giving way to a more targeted one.
A Fertility Specialist at Eraya Fertility works with couples navigating unexplained and recurrent IVF failure, using a diagnostic-first approach that looks beyond embryo grading to the uterine, genetic and gamete-level factors that can quietly derail an otherwise viable cycle.
According to Dr. Aishwarya Nupur, Founder & Director, Eraya Fertility, “
When a high-grade embryo fails to implant, it is rarely a matter of bad luck alone. It indicates a biological misalignment between the embryo’s genetic viability and the uterine microenvironment. Modern fertility care relies on systematically identifying that specific breakdown point, rather than repeating identical protocols.”
Fertility Specialist Dr. Aishwarya Nupur Explains – What Is Recurrent Implantation Failure (RIF)?
RIF is generally defined as three or more consecutive failed IVF cycles in a patient under 40, despite the transfer of morphologically normal, high-grade embryos. The condition has long been one of the most frustrating scenarios in reproductive medicine, precisely because the embryos involved often look entirely healthy. Today, a broader set of diagnostic tools allows specialists to investigate why implantation isn’t occurring, rather than attributing it to chance.
From Visual Grading to Precision Diagnostics
In a conventional IVF cycle, embryo selection relies heavily on visual grading under a microscope — how the cells are dividing, how the embryo is structured. That grading remains a useful baseline, but it does not reveal an embryo’s chromosomal health, and it says nothing about whether the uterus is actually prepared to receive it.
Her approach to resolving repeated failure centres on four areas of investigation.
Uterine and endometrial evaluation. This involves checking for intrauterine adhesions, polyps, chronic endometritis or structural abnormalities that can quietly interfere with implantation.
Genetic and chromosomal screening. This identifies aneuploidy in embryos that appear healthy under the microscope but are not chromosomally capable of sustaining a pregnancy.
Advanced gamete quality assessment. This goes beyond a standard semen analysis to evaluate factors such as Sperm DNA Fragmentation (SDF), which basic parameters can miss.
Implantation timing. This examines whether a patient’s individual “window of implantation” differs from the standard timeline typically assumed in a protocol.
The Diagnostic Tools Behind the Approach
Several tools now allow specialists to test each of these areas directly, rather than relying on assumption.
Preimplantation Genetic Testing (PGT-A) involves biopsying a small number of cells from a blastocyst to screen for missing or extra chromosomes before transfer, which helps reduce miscarriage risk and ensures that only genetically viable embryos are used.
Endometrial Receptivity Analysis (ERA) examines gene expression in the endometrial lining to determine whether a patient’s progesterone window needs to be personalised, identifying the specific hours when the uterus is receptive.
Microfluidic sperm selection and Magnetic-Activated Cell Sorting (MACS) help isolate sperm with stronger DNA integrity for use in ICSI, reducing the male-factor contribution to embryonic arrest.
High-resolution 3D ultrasonography and diagnostic hysteroscopy provide a direct view of the uterine cavity, allowing specialists to identify and treat subtle adhesions, inflammation or structural issues before a subsequent transfer is attempted.
What This Means for Patients
For a couple who has already been through several failed transfers, this shift matters in a practical way. It moves the conversation from “let’s try again” to “let’s find out what specifically went wrong.” That can mean additional testing before the next cycle, but it also means a more targeted transfer —and, for many patients, ultimately a shorter path to pregnancy, even though the added testing may not feel that way in the moment.
More diagnostics is not automatically the right answer for every patient, however. She emphasises that testing should be guided by a patient’s individual history rather than applied as a blanket protocol to everyone who has experienced a failed cycle.
Also Read: IVF in India 2026: Why India Is the Top Destination for Fertility Treatment
Questions Worth Asking After a Failed Cycle
Fertility specialist Dr Aishwarya Nupur recommends that patients raise the following with their clinical team before beginning another cycle:
- What was the developmental progression of the embryos transferred — Day 3 or Day 5 blastocysts — and were there signs of embryonic arrest?
- Have structural uterine issues, chronic inflammation or receptivity timing been ruled out through imaging or biopsy?
- Has sperm DNA fragmentation been assessed, beyond a standard count-and-motility semen analysis?
- Based on this cycle’s results, what specific protocol changes are being recommended, and why?
Also Read: The Heal in India Initiative 2026: Why India is the New Global Superpower in Medical Tourism
Where Reproductive Medicine Is Headed
The next phase of this field is likely to move toward less invasive testing, not more. Non-invasive preimplantation genetic testing (niPGT) and AI-assisted embryo assessment are both progressing toward delivering the same — or better — information with less biopsy and less manual evaluation.
Her central point is simple: a failed cycle involving a good embryo is not the end of the story — it is a diagnostic clue. Identifying the specific breakdown point, whether uterine, genetic, or gamete-related, turns a repeat failure into a workable plan.
The Path Forward
Recurrent implantation failure can be an exhausting experience for couples, both physically and emotionally. But a repeated setback is not necessarily a dead end — it is often a signal that the underlying cause simply hasn’t been identified yet. With the diagnostic tools now available, specialists are far better equipped to find that cause and adjust treatment accordingly, rather than repeating a cycle that has already failed once, twice, or more.
For patients who have been through multiple unsuccessful transfers, the most useful next step is often not another attempt at the same protocol, but a conversation with a specialist about what hasn’t been tested yet. That shift in approach — from repetition to investigation — is what is changing outcomes for many couples navigating this stage of their fertility journey.
About Fertility Specialist Dr. Aishwarya Nupur
Dr. Aishwarya Nupur is Founder & Director of Eraya Fertility and a fertility specialist with over 13 years of experience in reproductive medicine. She holds an MBBS, MS (ObGyn), Fellowship in Reproductive Medicine, and Diploma in Advanced Fertility. Her areas of expertise include fertility preservation and recurrent implantation failure. She is regularly invited as faculty and trainer at national medical conferences and contributes to discussions on emerging advancements in fertility care. Dr. Nupur is a member of IFS, ISAR, FOGSI, ASRM, ESHRE, FPSI, and a Patron Member of the PCOS Society of India.
Disclaimer: This article “Fertility Specialist Dr. Aishwarya Nupur Explains: How Advanced Diagnostics Are Helping Couples Overcome Recurrent Implantation Failure” is intended for general health education and does not replace an individual medical consultation. The suitability of any minimally invasive procedure depends on the patient’s specific condition and should be determined by a qualified medical professional.
